Redeye updates its estimates and valuation following Eniro's Q2 2025 report and a change of lead analyst. The report was broadly below our estimates, where a 16% y/y sales decline in Dynava is seen as the main surprise. We lower our estimates somewhat across the forecasting period, and make a few valuation-related changes as a result of the analyst change. Our fair value range is lowered, although with slightly mixed effects across our three different scenarios.
LÄS MER
